(Total Views: 191)
Posted On: 08/16/2021 2:23:47 PM
Post# of 107257
Nasdaq : $ACER Acer Therapeutics Reports Q2 2021 Financial Results and Provides Corporate Update
NEWTON, Mass., Aug. 10, 2021 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and life-threatening diseases with significant unmet medical needs, today reported financial results for the second quarter ended June 30, 2021 and provided an update on the Company’s recent corporate developments.
https://finance.yahoo.com/news/acer-therapeut...00415.html
NEWTON, Mass., Aug. 10, 2021 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and life-threatening diseases with significant unmet medical needs, today reported financial results for the second quarter ended June 30, 2021 and provided an update on the Company’s recent corporate developments.
https://finance.yahoo.com/news/acer-therapeut...00415.html
(0)
(0)
